SLU7 and cyclic hematopoiesis: Overall, most variants found in CH affected epigenetic modifiers (53/199 variants [73%] in 102/127 individuals [83%]), while mutations in splicing factors, signaling pathways and transcription factors were more commonly associated with overt myeloid malignancy (Supplementary Fig. 2).